Optical coherence tomographic assessment of macular thickness in diabetic macular edema : Prognosis after modified grid photocoagulation / Rasha Anwar Elsayed ; Supervised Magda Salah Eldin Abdelaziz , Amr Asar Khafagy , Nashwa Mohamed Badr Eldeen
Material type:
TextLanguage: English Publication details: Cairo : Rasha Anwar Elsayed , 2015Description: 105 P. : facsimiles ; 25cmOther title: - تقييم سمك المقولة فى مرض الإرتشاح السكرى بواسطة الأشعة المترابطة المقطعية على الشبكية بعد العلاج بالليزر [Added title page title]
- Issued also as CD
| Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
|---|---|---|---|---|---|---|---|
Thesis
|
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.24.M.Sc.2015.Ra.O (Browse shelf(Opens below)) | Not for loan | 01010110068347000 | ||
CD - Rom
|
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.24.M.Sc.2015.Ra.O (Browse shelf(Opens below)) | 68347.CD | Not for loan | 01020110068347000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Ophthalmology
Is to compare the macular thickness before and after modified grid laser photocoagulation treatment of clinically significant macular edema (CSME) in diabetic patients using optical coherence tomography (OCT) and to detect the effect of the change in the macular thickness on the visual prognosis. This is a single group, prospective interventional study that was performed on thirty eyes of 19 patients with clinically significant diabetic macular oedema undergoing OCT macular scanning before, 6 weeks and 3 months after receiving modified grid photocoagulation. Showed that the mean BCVA showed no statistical significant change throughout the 3 months follow up period and also the mean central macular thickness showed no statistical significant change throughout the follow up period. Patients with DME have not good benefit from modified grid photocoagulation and will need alternative or adjunct treatments such as intravitreal triamcinolone acetonide (IVTA) and therapies using inhibitors of vascular endothelial growth factor VEGF
Issued also as CD
There are no comments on this title.